| |
| |
|
| Insider
Information: |
Czirr James C |
| Relationship: |
10% Owner |
| City: |
Sandpoint |
| State: |
ID |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
6,168,940 |
|
|
Indirect Shares
|
5,922,207 |
|
|
| Direct
Value |
$13,756,736 |
|
|
|
Indirect Value
|
$13,206,522 |
|
|
| Total
Shares |
12,091,147 |
|
|
| Total
Value |
$26,963,258 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -98.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Galectin Therapeutics Inc |
GALT |
10% Owner |
2022-07-22 |
6,168,940 |
2024-04-23 |
5,922,207 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
107 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2004-12-20 |
5 |
GD |
$0.00 |
$0 |
D/D |
131,000 |
4,548,768 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • – |
2013-11-01 |
4 |
OE |
$3.00 |
$450,000 |
I/I |
150,000 |
9,407,422 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • – |
2015-01-31 |
4 |
OE |
$1.80 |
$300,001 |
D/D |
166,667 |
976,798 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2005-12-27 |
5 |
GD |
$0.00 |
$0 |
D/D |
186,000 |
4,352,268 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2005-12-27 |
5 |
GA |
$0.00 |
$0 |
I/I |
187,000 |
390,000 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2007-12-28 |
5/A |
GA |
$0.00 |
$0 |
I/I |
198,000 |
616,200 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2007-12-28 |
5 |
GA |
$0.00 |
$0 |
I/I |
198,000 |
588,000 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2007-12-28 |
5 |
GD |
$0.00 |
$0 |
D/D |
200,000 |
3,970,268 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2007-12-28 |
5/A |
GD |
$0.00 |
$0 |
D/D |
200,000 |
3,970,268 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2007-12-28 |
5/A |
GD |
$0.00 |
$0 |
D/D |
200,000 |
3,847,268 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-01-25 |
4 |
S |
$5.45 |
$1,118,035 |
I/I |
(205,144) |
3,160,284 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • • |
2011-09-30 |
4 |
A |
$0.92 |
$190,186 |
I/I |
206,724 |
9,069,422 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-06-13 |
4 |
AS |
$6.59 |
$1,493,276 |
I/I |
(208,140) |
2,801,646 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2016-12-31 |
4 |
A |
$1.01 |
$213,995 |
D/D |
211,876 |
3,452,303 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2016-12-31 |
4/A |
A |
$1.01 |
$213,995 |
I/I |
211,876 |
2,923,794 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2009-09-30 |
4 |
A |
$0.33 |
$72,315 |
I/I |
219,136 |
420,804 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2016-10-13 |
4 |
D |
$1.13 |
$259,203 |
I/I |
(229,383) |
3,196,115 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2009-01-21 |
4 |
S |
$0.08 |
$20,000 |
D/D |
(250,000) |
3,597,268 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2009-12-31 |
4 |
A |
$0.28 |
$72,808 |
I/I |
260,027 |
680,831 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • – |
2013-10-16 |
4 |
OE |
$3.00 |
$900,000 |
I/I |
300,000 |
9,257,422 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2010-03-31 |
5 |
A |
$0.44 |
$132,859 |
I/I |
301,952 |
982,783 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2010-06-30 |
5 |
A |
$0.71 |
$254,191 |
I/I |
358,015 |
1,340,798 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2010-09-30 |
5 |
A |
$0.79 |
$300,575 |
I/I |
380,475 |
1,721,273 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2010-12-31 |
5 |
A |
$0.90 |
$342,428 |
I/I |
380,475 |
2,101,748 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Executive Chairman |
• • • |
2011-03-31 |
4 |
A |
$1.04 |
$395,694 |
I/I |
380,475 |
2,482,223 |
0 |
- |
|
107 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
